Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Foghorn Therapeutics Inc. (FHTX)

NASDAQ

$4,12

$-0,25

(-5,73%)

Pre-Market

Foghorn Therapeutics Inc. (FHTX) Live Price Chart

Last updated: ⁦2026-09-16 10:31:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Foghorn Therapeutics Inc. (FHTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4,12, with a market capitalisation of $258,92M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3,27 to $7,61. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$258,92M
Open	$4,35
Day's High	$28,27
Day's Low	$2,70
Previous Close	$4,36
Volume	382,01K
Average Volume	341,85K
P/E Ratio	--
52-Week High	$7,61
52-Week Low	$3,27
Dividend Yield	--
Earnings Date	--

Foghorn Therapeutics Inc. (FHTX) Pre-Market Stock Price

Foghorn Therapeutics Inc. (FHTX) is trading at $4,44 in pre-market trading as of 2026-09-15 23:31:00, up 1,72% ($0,07) from the previous close of $4,36

Pre-market trading shows how investors are pricing FHTX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Foghorn Therapeutics Inc. (FHTX) 7-Day Stock Price Change

Over the past seven days, Foghorn Therapeutics Inc. (FHTX) moved from $4,92 to $4,12, representing a decline of 16,34% ($0,80).

The stock traded between $4,09 and $5,00 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 319,79 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

FHTX 52-Week Price Position

Position in Range: 19,5%

52W Low$3,27

52W High$7,61

FHTX is currently trading at $4,12, placing it 19,5% of the way from its 52-week low of $3,27 to its 52-week high of $7,61. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Foghorn Therapeutics Inc. (FHTX)?

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Foghorn Therapeutics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	106
Exchange	NASDAQ
Company Website	https://www.foghorntx.com

How to Buy Foghorn Therapeutics Inc. (FHTX) Stock on MEXC

Eligible investors can buy real shares of Foghorn Therapeutics Inc. (FHTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for FHTX and Place Your Order

Open the RealStocks trading page and search for FHTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Foghorn Therapeutics Inc. (FHTX) stock price today?

Foghorn Therapeutics Inc. (FHTX) is currently trading at $ 4,12, down 5,60% ($0,24) from the previous close of $ 4,36. Intraday prices update in real time during regular trading hours.

2.Is FHTX stock going up or down today?

As of 2026-09-15 23:31:00, FHTX is trading at $ 4,12, down 5,60% ($0,24) from its previous close of $ 4,36. The stock has traded between $ 2,70 and $ 28,27 during today’s regular session. Past price movements do not guarantee future results.

3.What is FHTX pre-market price?

As of 2026-09-15 23:31:00, FHTX is trading at $ 4,44 in pre-market trading, up 1,72% ($0,07) from the previous close of $ 4,36. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is FHTX after-hours price?

As of 2026-09-15 23:31:00, FHTX is trading at $ 4,23 in after-hours trading, down 2,96% ($0,13) from the regular-session close of $ 4,36. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is FHTX stock trading now?

FHTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does FHTX sit relative to its 52-week high and low?

Over the past 52 weeks, FHTX has traded between a low of $ 3,27 and a high of $ 7,61. At $ 4,12, the stock is positioned 19,5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Foghorn Therapeutics Inc. in?

Foghorn Therapeutics Inc. (FHTX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Foghorn Therapeutics Inc.'s market capitalisation and where is it listed?

Foghorn Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 258,92M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is FHTX valued in terms of P/E ratio and EPS?

FHTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1,09. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Foghorn Therapeutics Inc. pay a dividend?

Foghorn Therapeutics Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.